Status:
COMPLETED
Patient-Reported Outcomes Version of Common Terminology Criteria (CTCPRO) Cognitive Debriefing
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Advanced Cancers
Hematologic Diseases
Eligibility:
All Genders
18+ years
Brief Summary
The scientific aim of this study is to evaluate patient comprehension of the 77 newly developed items as well as the extent to which the items correspond to the concepts of interest for each patient r...
Detailed Description
Screening: The study staff will talk to your doctor or nurse, and/or look at your medical record, to see if you are currently receiving treatment. The study staff will also look at your medical recor...
Eligibility Criteria
Inclusion
- Patients must be aged 18 and over
- Able to read and understand English
- Patients with a high school education or less
- Patients who are undergoing chemotherapy or radiotherapy with curative or palliative intent.
- Patient is able to provide informed consent.
- All types of cancer diagnosis
Exclusion
- 1\) Significant cognitive impairment as determined by research staff's judgment
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00909207
Start Date
July 1 2009
Last Update
July 14 2014
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Dana-Farber Cancer Institute
Boston, Massachusetts, United States, 02115
2
Memorial Sloan-Kettering Cancer Center
New York, New York, United States, 10065
3
Duke University Medical Center
Durham, North Carolina, United States, 27708
4
UT MD Anderson Cancer Center
Houston, Texas, United States, 77030